Text Size

A Theory Based HIV Prevention Video For Rapid HIV Testing: A Randomized Trial

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2005 by North Bronx Healthcare Network.
Recruitment status was  Active, not recruiting
Sponsor:
Information provided by:
North Bronx Healthcare Network
ClinicalTrials.gov Identifier:
NCT00250549
First received: November 7, 2005
Last updated: November 16, 2005
Last verified: May 2005
History of Changes
  Purpose

OraQuick is a safe, rapid test that accurately identifies HIV in as little as 20 minutes. By providing an accurate, quick method for detecting a person’s serostatus and access to immediate post-test counseling, rapid testing has a crucial role in identifying HIV status and improving post-test counseling rates in populations who are at high risk of HIV infection and high failure to return rates. This prospective randomized control trial compared the educational effectiveness of a fifteen-minute post-test counseling video with the normal practice of a session with an HIV counselor.


Condition Intervention
Rapid HIV Testing
 Behavioral: Post test video

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Bio-equivalence Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention

Resource links provided by NLM:

MedlinePlus related topics: HIV/AIDS
U.S. FDA Resources

Further study details as provided by North Bronx Healthcare Network:

Primary Outcome Measures:
  • Mean Knowledge Score within both groups.

Secondary Outcome Measures:
  • Overall condom intention measures and Condom Self efficacy measures

Estimated Enrollment: 130
Study Start Date: May 2005
Estimated Study Completion Date: October 2005
Detailed Description:

A convenience sample of stable patients presenting to the walk-in section of the Jacobi Medical Center Adult ED were recruited for rapid HIV testing. After consenting for the rapid HIV test and completing measures on condom intention and condom use self-efficacy, participants were randomized to either a fifteen-minute HIV post-test educational video available in English or to an HIV counselor for post-test counseling. Afterwards, both groups completed a measure of HIV knowledge assessing relevant testing information and level of satisfaction. An equivalence analysis was carried out to assess whether the video was at least as good as counseling, measured by total score on the knowledge questionnaire, with a lower equivalence bound of -5%.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • All adult patients presenting to the Urgent Care Area at Jacobi Medical Center

Exclusion Criteria:

  • Patients that were in to much pain, unable to understand the consent process or spoke another language other than the languages offered via the video or were HIV tested with in 6 months.
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00250549

Locations
United States, New York
Jacobi Medical Center
Bronx, New York, United States, 10461
Sponsors and Collaborators
North Bronx Healthcare Network
Investigators
Principal Investigator: Yvette Calderon, MD, MS Jacobi Medical Center
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00250549     History of Changes
Other Study ID Numbers: 03-190
Study First Received: November 7, 2005
Last Updated: November 16, 2005
Health Authority: United States: Institutional Review Board

Keywords provided by North Bronx Healthcare Network:
HIV
Prevention
Rapid HIV testing

ClinicalTrials.gov processed this record on May 21, 2013